[1]
|
Chen, W.Q., Zheng, R.S., Baade, P.D., Zhang, S.W., Zeng, H.M., Bray, F., Jemal, A., Yu, X.Q. and He, J. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132.
https://doi.org/10.3322/caac.21338
|
[2]
|
Feng, R.-M., Zong, Y.-N., Cao, S.-M. and Xu, R.-H. (2019) Current Cancer Situation in China: Good or Bad News from the 2018 Global Cancer Statistics? Cancer Communications, 39, 22. https://doi.org/10.1186/s40880-019-0368-6
|
[3]
|
王永洁, 唐洁冰, 陶冀. 淋巴结阴性胃癌患者预后影响因素的研究进展[J]. 癌症进展, 2019, 17(13): 1498-1500+1594.
|
[4]
|
刘春晓, 王海磊, 冯美燕, 王国富, 薛英威, 王宽. 检测pT1-4aN1-3M0期胃癌淋巴结微转移检测的临床意义[J].现代生物医学进展, 2015, 15(31): 6053-6056+6159.
|
[5]
|
Zhou, Y., Zhang, G.-J., Wang, J., Zheng, K.-Y. and Fu, W.H. (2017) Current Status of Lymph Node Micrometastasis in Gastric Cancer. Oncotarget, 8, 51963-51969. https://doi.org/10.18632/oncotarget.17495
|
[6]
|
李子禹, 王胤奎, 陕飞, 季加孚. 早期胃癌治疗的共识与问题[J]. 中国实用外科杂志, 2018, 38(2): 153-157.
|
[7]
|
Sonoda, H. and Tani, T. (2014) Clinical Significance of Molecular Diagnosis for Gastric Cancer Lymph Node Micrometastasis. World Journal of Gastroenterology, 20, 13728-13733. https://doi.org/10.3748/wjg.v20.i38.13728
|
[8]
|
Jeuck, T.L.A. and Wittekind, C. (2015) Gastric Carcinoma: Stage Migration by Immunohistochemically Detected Lymph Node Micrometastases. Gastric Cancer, 18, 100-108. https://doi.org/10.1007/s10120-014-0352-4
|
[9]
|
You, X.L., Wang, Y.J., Wu, J., Liu, Q.H., Chen, D.H., Tang, D. and Wang, D.R. (2019) Aberrant Cytokeratin 20 mRNA Expression in Peripheral Blood and Lymph Nodes Indicates Micrometastasis and Poor Prognosis in Patients with Gastric Carcinoma. Technology in Cancer Research & Treatment, 18, 1-13.
https://doi.org/10.1177/1533033819832856
|
[10]
|
Shoji, N., Takaaki, A., Yoshikazu, U. and Shigehiro, Y. (2017) Novel Surgical Approach Based on the Sentinel Node Concept in Patients with Early Gastric Cancer. Annals of Gastroenterological Surgery, 1, 180-185.
https://doi.org/10.1002/ags3.12027
|
[11]
|
夏加增, 孙晓光, 赵伟, 周宏, 姚路斌. 病检阴性胃癌淋巴结转移的检测: 免疫组化和RT-PCR的比较[J]. 南通大学学报(医学版), 2005(3): 164-165+168.
|
[12]
|
高洋, 李姝, 项鹏程, 虞飞, 冯立文, 岳林, 王梦琪, 白雪峰. CEA、PCK蛋白在胃癌淋巴结微转移中的表达及其临床意义[J]. 诊断病理学杂志, 2019, 26(9): 609-611.
|
[13]
|
Nummela, P., Leinonen, H., Jrvinen, P., et al. (2016) Expression of CEA, CA19-9, CA125, and EpCAM in Pseudomyxoma Peritonei. Human Pathology, 54, 47-54. https://doi.org/10.1016/j.humpath.2016.02.022
|
[14]
|
尤小兰. CK20在胃癌患者外周血、淋巴结中的表达及其对预后的预测价值[D]: [博士学位论文]. 苏州: 苏州大学, 2016.
|
[15]
|
陈宏, 余元龙, 邓庆炎, 等. 胃癌中血管内皮生长C的表达与淋巴结微转移的关系[J/CD]. 中华普通外科学文献(电子版), 2011, 5(5): 413-417.
|
[16]
|
邓庆炎, 陈宏, 雒洪志, 张倩. 血管内皮生长因子C对胃癌淋巴结转移及微转移的预测价值研究[J]. 中华普通外科学文献(电子版), 2018, 12(6): 405.
|
[17]
|
王连文, 崔艳芳, 刘敬波, 白玉, 李娜, 袁笑, 李金玲. 角蛋白18、CEA、CA19-9、CA72-4在胃癌诊断中的成本-效果分析[J]. 滨州医学院学报, 2016, 39(5): 346-349.
|
[18]
|
张明亮, 黄允宁, 卢林, 李智勇, 马强波, 马海雁, 靳丁丁, 徐远义, 赵帅, 封存志. 以CK19为标记物研究pN0胃窦癌区域淋巴结微转移[J]. 宁夏医学杂志, 2017, 39(1): 36-38.
|
[19]
|
张永乐, 薛英威, 蓝秀文, 马岩, 魏玉哲, 杨丽. 肿瘤标记物CA19-9、CEA对胃癌转移和预后预测价值的分析[J]. 哈尔滨医科大学学报, 2010, 44(2): 181-184+188.
|
[20]
|
孙洁, 孟祥军. 血清CA199、CEA、CA125、CA724联合检测在胃癌诊断中的价值[J]. 中国实验诊断学, 2014, 18(12): 1936-1939.
|
[21]
|
龚根强, 杨维桢. 术前血清CA19-9水平对胃癌患者淋巴结微转移的预测价值及其对预后的影响[J]. 中国普外基础与临床杂志, 2018, 25(1): 65-70.
|
[22]
|
许威, 刘宏斌. 血清癌胚抗原、基质金属蛋白酶3、血管内皮生长因子与胃癌微转移及预后关系的研究进展[J]. 医学综述, 2013, 19(11): 1982-1985.
|
[23]
|
Zhao, F.J., Zhang, Q.Y., Kang, C.S., Cui, X.W., Wang, T., Xu, P., Zhou, X., Liu, J. and Song, X.M. (2010) Suppression of Matrix Metalloproteinase-9 Expression by RNA Interference Inhibits SGC7901 Gastric Adenocarcinoma Cell Growth and Invasion in Vitro and in Vivo. Medical Oncology, 27, 774-784. https://doi.org/10.1007/s12032-009-9285-x
|
[24]
|
Li, Z., Zhang, D.W., Zhang, H., Miao, Z.F., Tang, Y.X., Sun, G.P. and Dai, D.Q. (2014) Prediction of Peritoneal Recurrence by the mRNA Level of CEA and MMP-7 in Peritoneal Lavage of Gastric Cancer Patients. Tumor Biology, 35, 3463-3470. https://doi.org/10.1007/s13277-013-1458-8
|
[25]
|
Lee, C.M., Cho, J.-M., Jang, Y.-J., Park, S.-S., Park, S.-H., Kim, S.-J., Mok, Y.-J., Kim, C.-S. and Kim, J.-H. (2015) Should Lymph Node Micrometastasis Be Considered in Node Staging for Gastric Cancer? The Significance of Lymph Node Micrometastasis in Gastric Cancer. Annals of Surgical Oncology, 22, 765-771.
https://doi.org/10.1245/s10434-014-4073-z
|
[26]
|
Blouhos, K., Boulas, K.A. and Hatzigeorgiadis, A. (2017) Clinical Significance of Lymph Nodes Micrometastasis in Conventionally Node-Negative Advanced Gastric Cancer. Updates in Surgery, 69, 425-426.
https://doi.org/10.1007/s13304-017-0420-5
|
[27]
|
吴泽宇, 彭林, 赵刚, 詹文华. 淋巴结微转移检测对判断胃癌预后的价值[J]. 实用医学杂志, 2010, 26(22): 4151-4153.
|
[28]
|
金俊蕊, 邓靖宇, 梁寒. 胃癌淋巴结分期的临床变革及分期方法的研究进展[J]. 中国肿瘤临床, 2016, 43(15): 683-689.
|
[29]
|
徐惠绵, 王鹏亮, 宫英博. 胃癌TNM分期优化及病理质量控制[J]. 中华胃肠外科杂志, 2020(1): 87-91.
|